Novartis Pharmaceuticals Corporation
59 Route 10
Appendix 10:
Advisory Board Attendees
Zometa® (zoledronic
acid) Injection
and
Aredia® (pamidronate disodium) Injection
Submitted:
Oncologic Drugs Advisory Committee Meeting
Property of Novartis Pharmaceuticals Corporation
All rights reserved
Available for public disclosure without
redaction
Robert Marx, DDS,
Salvatore Ruggiero, DMD, MD, Long Island Jewish Medical Center, New Hyde Park, NY;
Bela Toth,
Robert Coleman, MD, Professor of medical Oncology, Academic Unit of Oncology, Weston Park, Hospital, Sheffield, UK
Fred Singer, MD,
Jerry Bouquot, DDS, MSD, The Maxillofacial Center for Education and Research,
David Little, MBBS, FRACS, The Children’s Hospital at Westmead, Westmead, NSW Australia
Sol Epstein, MD,
Allan Lipton, MD, Professor of Medicine and
Oncology, Milton S. Hershey Medical Centrer,
Toshiyuki Yoneda, PhD, DDS, Professor,
UTHSC
Kathryn Damato,
Julie Gralow, MD, University of
Ana Hoff, MD,
Joseph Huryn, DDS,
Robert Marx, DDS,
Salvatore Ruggiero, DMD, MD, Long Island Jewish Medical Center, New Hyde Park, NY;
Mark Schubert, DDS, MDS,
Bela Toth, DDS, MS, University of Texas MD Anderson Cancer Center, Houston, Tex; Vicente Valero, MD, FACP, The University of Texas MD Anderson Cancer Center, Houston, Tex.
Harry Harper MD